Keyword: Oligonucleotides
News
10.10.2022
-
Swiss peptide and oligonucleotide specialist Bachem has agreed to buy an undeveloped site in Sisslerfeld from DSM. It has completed the purchase of a first plot, with...
News
22.09.2022
-
Bachem, a Swiss specialist developer and manufacturer of peptides and oligonucleotides, has announced the signing of two major contracts for supplying large volumes of...
Chemistry & Life Sciences
15.04.2022
-
The global market for oligonucleotide therapeutics is expanding rapidly. Bachem, an innovation-driven company based in Bubendorf, Switzerland, has entered this...
Chemistry & Life Sciences
04.12.2020
-
The global market for oligonucleotide therapeutics is expanding rapidly. Bachem, an innovation-driven company based in Bubendorf, Switzerland, has entered this...
News
26.02.2018
- Two drug development specialists based in the US state of California, STA Pharmaceutical, part of the WuXi AppTec group, and Regulus Therapeutics, have agreed to collaborate on...
26.09.2016
- Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...
